Intravitreal faricimab for neovascular age-related macular degeneration previously treated with traditional anti-VEGF compounds: a real-world prospective study

被引：0
|
作者：
Gabriela Grimaldi
Giuseppe Cancian
Angelica Rizzato
Alex Casanova
Kathrin Perruchoud-Ader
Michele Clerici
Andrea Consigli
Moreno Menghini
机构：
[1] Ente Ospedaliero Cantonale (EOC),Department of Ophthalmology, Institute of Clinical Neurosciences of Southern Switzerland (INSI)
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2024年 / 262卷
关键词：
Faricimab; Age-related macular degeneration; Treat-and-extend; Real-world data;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1151 / 1159
页数：8
相关论文
共 50 条
  • [41] Real-World Data on Faricimab Switching in Treatment-Refractory Neovascular Age-Related Macular Degeneration
    Ng, Benjamin
    Kolli, Hema
    Kumar, Naduviledeth Ajith
    Azzopardi, Matthew
    Logeswaran, Abison
    Buensalido, Julius
    Mushtaq, Bushra
    Chavan, Randhir
    Chong, Yu Jeat
    LIFE-BASEL, 2024, 14 (02):
  • [42] Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an overview
    Semeraro, Francesco
    Morescalchi, Francesco
    Duse, Sarah
    Gambicorti, Elena
    Romano, Mario R.
    Costagliola, Ciro
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (06) : 785 - 802
  • [43] Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an update
    Costagliola, Ciro
    Morescalchi, Francesco
    Duse, Sarah
    Romano, Davide
    Mazza, Giuseppina
    Parmeggiani, Francesco
    Bartollino, Silvia
    Semeraro, Francesco
    EXPERT OPINION ON DRUG SAFETY, 2019, 18 (09) : 803 - 815
  • [44] Short-Term Outcomes of Faricimab in Patients with Neovascular Age-Related Macular Degeneration on Prior Anti-VEGF Therapy
    Szigiato, Andrei
    Mohan, Nitesh
    Talcott, Katherine E.
    Mammo, Danny A.
    Babiuch, Amy S.
    Kaiser, Peter K.
    Ehlers, Justis P.
    Rachitskaya, Aleksandra
    Yuan, Alex
    Srivastava, Sunil K.
    Sharma, Sumit
    OPHTHALMOLOGY, 2024, 131 (02) : 128 - 129
  • [45] Initial Real-World Experience with Faricimab in Treatment-Resistant Neovascular Age-Related Macular Degeneration
    Leung, Ella H.
    Oh, Daniel J.
    Alderson, Shannon E.
    Bracy, Joshlynn
    McLeod, Mia
    Perez, Litzi, I
    Bottini, Alexander
    Yee, David Chin
    Mukkamala, Krishna
    CLINICAL OPHTHALMOLOGY, 2023, 17 : 1287 - 1293
  • [46] Short-Term Outcomes of Faricimab in Patients with Neovascular Age-Related Macular Degeneration on Prior Anti-VEGF Therapy
    Szigiato, Andrei
    Mohan, Nitesh
    Talcott, Katherine E.
    Mammo, Danny A.
    Babiuch, Amy S.
    Kaiser, Peter K.
    Ehlers, Justis P.
    Rachitskaya, Aleksandra
    Yuan, Alex
    Srivastava, Sunil K.
    Sharma, Sumit
    OPHTHALMOLOGY RETINA, 2024, 8 (01): : 10 - 17
  • [47] Cardiovascular risk in anti-VEGF treatment of neovascular age-related macular degeneration
    Chong, David D.
    Maatouk, Christopher M.
    Markle, Jonathan
    Shaia, Jacqueline K.
    Singh, Rishi P.
    Talcott, Katherine E.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2025, 60 (01): : 35 - 41
  • [48] Adjuvant radiotherapy during anti-VEGF in neovascular age-related macular degeneration
    Rating, P.
    Freimuth, M. -A.
    Stuschke, M.
    Bornfeld, N.
    OPHTHALMOLOGE, 2017, 114 (04): : 370 - 374
  • [49] Predictors of anti-VEGF treatment response in neovascular age-related macular degeneration
    Finger, Robert P.
    Wickremasinghe, Sanjeewa S.
    Baird, Paul N.
    Guymer, Robyn H.
    SURVEY OF OPHTHALMOLOGY, 2014, 59 (01) : 1 - 18
  • [50] Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration: Therapeutic Strategies
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2012, 229 (05) : 541 - 547
12345